(Press-News.org) INDIANAPOLIS, US and LONDON, UK – Regenstrief Institute and SNOMED International have released LOINC® Ontology 2.0, the next version of The LOINC Ontology: A LOINC and SNOMED CT Interoperability Solution and a significant advance in their ongoing collaboration to streamline the exchange and use of health data worldwide.
This version expands the Ontology with approximately 6,000 additional concepts, with more than 2,500 new “Orderable Grouper” concepts that provide practical, higher-level groupings for laboratory orders. By introducing this organization, called LABORDERS.ONTOLOGY, the partners are deepening their relationship and making it easier for implementers to deploy a broader range of LOINC and SNOMED CT concepts across health information systems.
Developed as a LOINC and SNOMED CT interoperability solution, the LOINC Ontology helps organizations that implement different combinations of the two standards meet clinical and regulatory requirements with a single, complementary approach. SNOMED CT supplies the computable framework, while LOINC contributes rich laboratory and pathology content in a widely understood format – benefiting implementers globally, including those in countries that do not yet use LOINC. The update is in response to international users who requested clearer navigation and application. Instead of working with a flat list of tens of thousands of concepts, implementers can now use this organization hierarchy to locate and manage related tests more efficiently.
Version 2.0 continues to support the ongoing development of standardized laboratory orders and results for exchange and use in health data systems globally. Each grouper combines component, system (specimen) and a new “measurement” property to group related result concepts, giving users an at-a-glance structure that encompasses three or more related tests. These concepts are designed for ordering, not for reporting results, and align with the granularity typical of laboratory order catalogs.
“Many laboratories need order codes that are more abstract than result codes,” said Marjorie Rallins, DPM, M.S., executive director of Health Data Standards at Regenstrief, which oversees LOINC. “With these new Orderable Grouper concepts, we’re giving the community a better way to align laboratory ordering practices with the rich specificity of LOINC. The LOINC Ontology is novel and transformative in providing clinical observation content in an integrated format that accelerates interoperability and supports stakeholders with meeting clinical and regulatory requirements.”
“Significant commitment and collaboration have gone into producing this Ontology,” said Don Sweete, CEO of SNOMED International. “SNOMED CT contributes the computable clinical framework, rigorous semantics and terminology that anchor the Ontology 2.0 hierarchy, enabling navigation, decision support, analytics and global interoperability alongside LOINC’s laboratory content. It’s an excellent illustration of how we’ve leveraged our mutual expertise to further the goal of interoperability for implementers globally.”
Key highlights of LOINC Ontology 2.0 include:
LABORDERS.ONTOLOGY concepts: Each combines component, system (specimen) and a new “measurement” property to group related result concepts.
Created for ordering, not results: These concepts provide a granularity consistent with typical laboratory order catalogs but should not be sent as result codes.
Clearer navigation: Users gain an “at a glance” structure that encompass three or more related result concepts for easier browsing.
Guidance and training: Tutorials and educational resources will be developed to support correct implementation and prevent misuse.
The LOINC Ontology is fully owned by Regenstrief Institute and is available free of charge under the existing LOINC royalty-free license. SNOMED International members and users can access LOINC in the same format as SNOMED CT. Each organization retains editorial control of its respective standard.
SNOMED International, a not-for-profit organization governed by 50 global members, sets global standards for health terminology. Its comprehensive, multilingual SNOMED CT enables healthcare professionals to capture, share and analyze patient care data to support safe, effective health information exchange.
In 2022, the two organizations signed a milestone agreement to create a LOINC extension of SNOMED CT. This built on a partnership established in 2013 that linked SNOMED’s clinical semantics to LOINC’s observational concepts, improving data exchange and interoperability across health systems.
For more information and to browse and download the Ontology, visit https://loincsnomed.org.
About LOINC®
LOINC® was created in 1994 at Regenstrief Institute to facilitate interoperability in healthcare. There was a growing trend to send clinical data electronically between healthcare entities, a practice that has now become ubiquitous. Today, it contains more than 108,000 concepts for everything from an albumin level to a zygomatic arch X-ray report. For each concept, LOINC contains many other rich details, such as synonyms, units of measure and carefully crafted descriptions.
About SNOMED International
SNOMED International is a not-for-profit organization that owns and develops SNOMED CT, the world’s most comprehensive healthcare terminology product. We play an essential role in improving the health of humankind by determining standards for a codified language that represents groups of clinical terms. This enables healthcare information to be exchanged globally for the benefit of patients and other stakeholders. We are committed to the rigorous evolution of our products and services, to deliver continuous innovation for the global healthcare community. SNOMED International is the trading name of the International Health Terminology Standards Development Organisation. https://www.snomed.org.
About Regenstrief Institute
Regenstrief Institute, based in Indianapolis, is a globally renowned medical research organization with expertise and innovation in aging, health services and biomedical informatics research, global health standards and data stewardship. The organization collaborates with local, state, national and international public and private sector partners to develop, conduct, disseminate and implement impactful scientific research and solutions in health systems and across communities. The Institute’s vision is to engage in pioneering, transformative, interdisciplinary solutions for a healthier world.
END
Ontology 2.0 deepens LOINC®-SNOMED collaboration, speeds global lab interoperability
2025-09-29
ELSE PRESS RELEASES FROM THIS DATE:
Cornell launches initiative to unravel the science of menopause
2025-09-29
ITHACA, N.Y. -- Two centuries ago, few women lived long enough to reach menopause. Today, it marks a major inflection point in women’s health, yet remains poorly understood. Cornell researchers aim to change that.
Drawing on cutting-edge technology and interdisciplinary expertise, researchers are launching Menopause Health Engineering, a new initiative uniting faculty from Cornell’s Ithaca campus and Weill Cornell Medicine, to uncover how menopause shapes health and disease, and to develop urgently needed treatment ...
Reform of federal drug discount program should target misaligned incentives
2025-09-29
The dramatic growth of a key federal drug discount program has fueled debate about whether it is helping low-income patients as intended or primarily benefiting healthcare providers.
Congress created the 340B Drug Pricing Program over 30 years ago to help hospitals and clinics that serve high levels of uninsured patients purchase outpatient drugs from manufacturers at significantly discounted prices. However, the law does not require participating providers to pass on discounts to patients or dedicate program funds to safety-net care.
A new white paper from the USC Schaeffer Center for Health Policy & Economics traces how major eligibility expansions and distorted program incentives ...
Variation in US commercial health plan coverage restrictions for cell and gene therapies
2025-09-29
About The Study: For Food and Drug Administration (FDA)-approved cell and gene therapies, commercial health plans commonly imposed coverage requirements beyond FDA-approved product labeling. These restrictions were often aligned with pivotal trial criteria, suggesting that plan coverage aligns with stronger supporting evidence.
Corresponding Author: To contact the corresponding author, James D. Chambers, PhD, email james.chambers@tuftsmedicine.org.
To access the embargoed study: Visit our For The Media website at this ...
Motivational and mobile-based support improved child passenger safety behaviors, clinical trial finds
2025-09-29
Parents improved use of appropriate child car seats after remote motivational counseling and mobile-based support, according to the results from a randomized clinical trial published in JAMA Network Open. The intervention included tailored web content, periodic text messages and personalized feedback on photos parents submitted every four to six weeks showing how their child usually travels in a car.
“Parents and children might resist using the recommended car seat or booster seat, even though it’s the law, due to inconvenience or beliefs that their child is safe enough riding ...
Population-level effectiveness and herd protection 17 years after HPV vaccine introduction
2025-09-29
About The Study: In this study, population-level effectiveness and herd protection were robust 17 years after human papillomavirus (HPV) vaccine introduction, even in sexually experienced adolescent girls and young women at relatively high risk for HPV who may not have received the full vaccination series.
Corresponding Author: To contact the corresponding author, Jessica Kahn, MD, MPH, email jessica.kahn@einsteinmed.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamapediatrics.2025.3568)
Editor’s Note: Please see the article for additional ...
Modeling the health impact of discontinuing COVID-19 vaccination during pregnancy in the US
2025-09-29
About The Study: This decision analytical model study estimates that COVID-19 vaccination (primarily annual COVID-19 vaccination) during pregnancy will likely continue to yield meaningful public health benefits in the U.S., especially to reduce COVID-19 hospitalizations in infants. COVID-19 vaccination during pregnancy has been shown to be safe. While there is global variation in policy recommending COVID-19 vaccination during pregnancy, the U.S. has a high risk of severe COVID-19 in newborns, underscoring relevance of maternal COVID-19 vaccination.
Corresponding ...
The rise in early-onset cancer in the US population— more apparent than real
2025-09-29
About The Study: The rise in early-onset cancer incidence does not consistently signal a rise in the occurrence of clinically meaningful cancer. While some of the increase in early-onset cancer is likely clinically meaningful, it appears small and limited to a few cancer sites. Much of the increase appears to reflect increased diagnostic scrutiny and over-diagnosis. Interpreting rising incidence as an epidemic of disease may lead to unnecessary screening and treatment while also diverting attention from other more pressing health threats in young adults.
Corresponding Author: To contact the corresponding author, H. Gilbert Welch, MD, MPH, email drgilwelch@gmail.com.
To ...
Scientists reveal functional RNA splitting mechanism behind origin of Type V CRISPR systems
2025-09-29
CRISPR-Cas systems are adaptive immune systems found in prokaryotes that defend against invading nucleic acids through CRISPR RNA-guided cleavage. Type V CRISPR-Cas (Cas12) systems, in particular, serve as one of today’s most powerful tools for genome editing, especially in basic research, medicine, and agriculture.
Researchers led by Prof. GAO Caixia from the Institute of Genetics and Developmental Biology (IGDB) of the Chinese Academy of Sciences (CAS), together with Assoc. Prof. LIU Junjie from Tsinghua University ...
Study shows HPV vaccine protects vaccinated — and unvaccinated — women
2025-09-29
September 29, 2025 (BRONX, NY)—A large, long-term study led by an Albert Einstein College of Medicine researcher has found that the introduction of the human papillomavirus (HPV) vaccine in community settings is highly effective in protecting young women from infections caused by the cervical-cancer-causing virus—including women who didn’t even receive the vaccine. The study was published today in JAMA Pediatrics.
“There are two encouraging takeaways from our study,” said lead ...
Childhood overeating can be a harbinger of later mental health struggles in girls, study finds
2025-09-29
Girls who overeat regularly in the preschool years are more likely to experience anxiety, impulsivity and hyperactivity in adolescence, according to a new study led by researchers at McGill University and the Douglas Research Centre.
The study followed more than 2,000 Quebec children using provincial data, tracking eating patterns reported by caregivers in early childhood and assessing mental-health symptoms when participants turned 15. The link between overeating and later difficulties was seen in girls, but not in boys.
Takeaway for caregivers
The findings ...